Improve therapeutic monoclonal antibody selection by knowing protein stability using Prometheus

Everyday researchers face the daunting challenge of creating more effective biotherapeutics. Many candidates fail due to a lack of critical stability information that’s tightly linked to function and efficacy. Scientists deserve a technology early on in their research that reveals deep bioanalytical characterization. Prometheus quickly and precisely measures conformational and colloidal stability of any protein. Examples of optimizing storage/buffer formulation conditions and functional screening to identify better biotherapeutic targets using Prometheus will be discussed.

Previous
Predicting the aggregation propensity of mAbs using chemical and thermal denaturation on a Single, Fully Automated Platform
Predicting the aggregation propensity of mAbs using chemical and thermal denaturation on a Single, Fully Automated Platform

Up next
Measuring stability to more effectively select therapeutic antibody candidates
Measuring stability to more effectively select therapeutic antibody candidates

This therapeutic antibody drug development webinar discusses the idea of limiting the substantial investmen...

Looking for the optimal formulation for your biologics candidates?

NanoTemper tools can help

Find out how